Matches in Nanopublications for { ?s ?p "[The PI3K inhibitor PX-866 had anti-tumor efficacy in HNSCC models with PIK3CA alterations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP1071422.RABbfXDrOjZzgmZSDkCOI0FINaNV943nXZ0DsvMdh6ULw130_assertion description "[The PI3K inhibitor PX-866 had anti-tumor efficacy in HNSCC models with PIK3CA alterations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1071422.RABbfXDrOjZzgmZSDkCOI0FINaNV943nXZ0DsvMdh6ULw130_provenance.
- NP621900.RA1M90xlJEkfJ1EwtSQGQ5at9ggiMDuN8FLH1LSqcvZ2Y130_assertion description "[The PI3K inhibitor PX-866 had anti-tumor efficacy in HNSCC models with PIK3CA alterations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621900.RA1M90xlJEkfJ1EwtSQGQ5at9ggiMDuN8FLH1LSqcvZ2Y130_provenance.
- NP1071416.RAyll1ziUlYUGb-Okh79xrB5Y3DE9WbC2g4OLXZZCZG5U130_assertion description "[The PI3K inhibitor PX-866 had anti-tumor efficacy in HNSCC models with PIK3CA alterations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1071416.RAyll1ziUlYUGb-Okh79xrB5Y3DE9WbC2g4OLXZZCZG5U130_provenance.
- NP1071424.RA8Jv8xHg-KK56gD1CdGLFQTa6odgaPCt25ZuQyupOnl8130_assertion description "[The PI3K inhibitor PX-866 had anti-tumor efficacy in HNSCC models with PIK3CA alterations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1071424.RA8Jv8xHg-KK56gD1CdGLFQTa6odgaPCt25ZuQyupOnl8130_provenance.
- NP625554.RAFZkCES0a_EyuFBCvtc4fyPctkGmsiKjaFaEJiTEYPtQ130_assertion description "[The PI3K inhibitor PX-866 had anti-tumor efficacy in HNSCC models with PIK3CA alterations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625554.RAFZkCES0a_EyuFBCvtc4fyPctkGmsiKjaFaEJiTEYPtQ130_provenance.
- assertion description "[The PI3K inhibitor PX-866 had anti-tumor efficacy in HNSCC models with PIK3CA alterations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The PI3K inhibitor PX-866 had anti-tumor efficacy in HNSCC models with PIK3CA alterations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The PI3K inhibitor PX-866 had anti-tumor efficacy in HNSCC models with PIK3CA alterations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The PI3K inhibitor PX-866 had anti-tumor efficacy in HNSCC models with PIK3CA alterations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1071418.RAZ0cNl9AhXQoTTV12d5W4DbhI2QGbT7K3IdcrqYFnbbQ130_assertion description "[The PI3K inhibitor PX-866 had anti-tumor efficacy in HNSCC models with PIK3CA alterations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1071418.RAZ0cNl9AhXQoTTV12d5W4DbhI2QGbT7K3IdcrqYFnbbQ130_provenance.
- NP623098.RAm3JeIVlPEmWFfKZeEzW82b5kB3VPNKMIsCaWdejWhTw130_assertion description "[The PI3K inhibitor PX-866 had anti-tumor efficacy in HNSCC models with PIK3CA alterations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623098.RAm3JeIVlPEmWFfKZeEzW82b5kB3VPNKMIsCaWdejWhTw130_provenance.
- NP624413.RAlvLLzRWfwNjdLFk7kwtCFEvkj1SvSk0ortQ3gADSfnY130_assertion description "[The PI3K inhibitor PX-866 had anti-tumor efficacy in HNSCC models with PIK3CA alterations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624413.RAlvLLzRWfwNjdLFk7kwtCFEvkj1SvSk0ortQ3gADSfnY130_provenance.